The Impact of Targeted Estrogen Receptor (ER) Imaging on Breast Cancer Patients
Leading healthcare experts Dr. Hannah Linden and Dr. Gary Ulaner will offer their insights about a diagnostic imaging agent that may help inform physicians clinical decisions and treatment selection for people with recurrent or metastatic breast cancer.
Dr. Hannah Linden, Clinical Director of the Breast Cancer Program at the University of Washington/Fred Hutchinson Cancer Center.
Register to get instructions to join.
Wednesday, 3-4pm ET